Description
Walrycin B inhibits the walrycin response regulator (WalR). This compound exhibits antibacterial activity, altering cell wall metabolism and cell division in Bacillus and Staphylococcus.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Walrycin B inhibits the walrycin response regulator (WalR). This compound exhibits antibacterial activity, altering cell wall metabolism and cell division in Bacillus and Staphylococcus.
| Cas No. | 878419-78-4 |
|---|---|
| Purity | ≥98% |
| Formula | C14H10F3N5O2 |
| Formula Wt. | 337.26 |
| IUPAC Name | 1,6-Dimethyl-3-[4-(trifluoromethyl)phenyl]pyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione |
| Solubility | DMSO: 11.5 mg/mL |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Gotoh Y, Doi A, Furuta E, et al. Novel antibacterial compounds specifically targeting the essential WalR response regulator. J Antibiot (Tokyo). 2010 Mar;63(3):127-34. PMID: 20111065.
Calcium channel blocker.
RIP1 inhibitor.
ITC, erucin analog.
Endogenous cardiomodulatory peptide; NPR-A agon...
Staurosporine derivative; PKC and FLT3 inhibito...
Peptide, derivative of AT II, involved in vasoc...
HDAC inhibitor.
Oligopeptide found in Actinomycetes; protease i...
Zinc chelator
Alkaloid produced by Streptomyces, precursor in...
Niacin derivative.
Inhibitor of TRK.
Insect growth regulator; chitin synthesis inhib...
AhR antagonist.
Microtubule depolymerization inhibitor.
Enkephalinase inhibitor.
Glutamine analog; γ-glutamyl transferase, CTP ...
p110δ PI3K inhibitor.
FAAH inhibitor.
Nav1.7 and Nav1.8 N1+ channel blocker.